These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 27618142)

  • 41. Screening colonoscopy in the US: attitudes and practices of primary care physicians.
    Zapka J; Klabunde CN; Taplin S; Yuan G; Ransohoff D; Kobrin S
    J Gen Intern Med; 2012 Sep; 27(9):1150-8. PubMed ID: 22539065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic colonoscopy following a positive fecal occult blood test in community health center patients.
    Liss DT; Brown T; Lee JY; Altergott M; Buchanan DR; Newland A; Park JN; Rittner SS; Baker DW
    Cancer Causes Control; 2016 Jul; 27(7):881-7. PubMed ID: 27228991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attitudes toward colorectal cancer screening tests.
    Ling BS; Moskowitz MA; Wachs D; Pearson B; Schroy PC
    J Gen Intern Med; 2001 Dec; 16(12):822-30. PubMed ID: 11903761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
    Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
    Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada.
    Vahabi M; Lofters A; Wong JP; Ellison L; Graves E; Damba C; Glazier RH
    Cancer Med; 2019 Nov; 8(16):7108-7122. PubMed ID: 31568705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
    Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
    BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008.
    Bandi P; Cokkinides V; Smith RA; Jemal A
    Cancer; 2012 Oct; 118(20):5092-9. PubMed ID: 22434529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
    Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
    Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of colorectal cancer screening in diverse primary care practices.
    Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
    BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices.
    Correia A; Rabeneck L; Baxter NN; Paszat LF; Sutradhar R; Yun L; Tinmouth J
    Prev Med; 2015 Jul; 76():115-22. PubMed ID: 25895843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.
    Powell AA; Saini SD; Breitenstein MK; Noorbaloochi S; Cutting A; Fisher DA; Bloomfield HE; Halek K; Partin MR
    J Gen Intern Med; 2015 Jun; 30(6):732-41. PubMed ID: 25605531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary care physician characteristics associated with cancer screening: a retrospective cohort study in Ontario, Canada.
    Lofters AK; Ng R; Lobb R
    Cancer Med; 2015 Feb; 4(2):212-23. PubMed ID: 25430885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.